BARBARA MOORE: Open Payments
NPI 1831124932 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,402 in 159 payments from 25 companies in 2025. Trend: 2023 $1,724 · 2024 $1,702 · 2025 $2,402
Food & beverage: $2,402
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $260 |
| Abbott Laboratories | 17 | $253 |
| AstraZeneca Pharmaceuticals LP | 7 | $211 |
| Novo Nordisk Inc | 22 | $210 |
| ABBVIE INC. | 23 | $202 |
| Lilly USA, LLC | 10 | $197 |
| Axsome Therapeutics, Inc. | 10 | $176 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $152 |
| Amgen Inc. | 13 | $144 |
| Sumitomo Pharma America, Inc. | 5 | $87 |
Products named: FREESTYLE LIBRE 3, JARDIANCE, PREVNAR 20, Sunosi, FARXIGA, MOUNJARO, Ozempic, GEMTESA.
Industry payments across OK — which companies pay providers there.
